COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Quality of Life Intermittent Catheter Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01523743
Recruitment Status : Completed
First Posted : February 1, 2012
Results First Posted : May 22, 2014
Last Update Posted : September 30, 2016
Information provided by (Responsible Party):
Coloplast A/S

Brief Summary:
The purpose of this study is to compare compact intermittent catheters with standard coated intermittent catheters with regard to quality of life, using the Intermittent Self-Catheterisation Quality of life Measure.

Condition or disease Intervention/treatment Phase
Neurogenic Bladder Dysfunction Nos Device: SpeediCath Compact Device: Standard care Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 125 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Quality of Life Intermittent Catheter Study - A Prospective, Randomized, Cross-over, Multicenter Study Comparing Quality of Life Using Compact Versus Standard Urinary Intermittent Catheters
Study Start Date : November 2011
Actual Primary Completion Date : April 2012
Actual Study Completion Date : May 2012

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Compact catheter
Compact intermittent catheter
Device: SpeediCath Compact
The SpeediCath Compact intermittent catheter is used for single-use urinary bladder drainage through the urethra.
Other Names:
  • SpeediCath®Compact Male, for male participants
  • SpeediCath®Compact Female, for female participants

Active Comparator: Standard Care
Standard Care: Coated intermittent catheter normally used by subject
Device: Standard care
The coated intermittent catheter normally used by subject

Primary Outcome Measures :
  1. Quality of Life (0-100 Point) [ Time Frame: 6 weeks ]
    Difference in intermittent self-catheterisation quality of life measure, comparing compact versus standard urinary intermittent catheters The range of the scale is 0-100 where a high score indicating a high level of Quality of Life.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Is at least 18 years of age
  • Has given written informed consent
  • Has neurogenic bladder dysfunction
  • Has used coated intermittent catheter as primarily bladder emptying method for at least 6 months
  • Is able to self-catheterise
  • Is able to use SpeediCath® compact catheters
  • If spinal cord injury subject, injury must have occurred more than 12 months ago
  • Covered by Social security system

Exclusion Criteria:

  • Has used SpeediCath® compact catheters (not including screening for this investigation)
  • Is admitted to rehabilitation centre
  • Subjects using primarily catheter sets
  • Is pregnant or breast-feeding

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01523743

Layout table for location information
PrivatHospitalet Danmark, privat hospital,
Charlottenlund, Denmark
Rigshospitalet, Urology clinic,
Copenhagen, Denmark
CCBR Vejle, Clinical research site,
Vejle, Denmark
Hôpital Tenon, Neuro-Urology and perineal explorations department,
Paris, Cedex 20, France
Hôpital Raymond Poincaré, Urology clinic
Garches, France, 92350
Hôpital Léon Berard, Rehabilitation clinic,
Hyères cedex, France
Hôpital Henry Gabrielle, Urology clinic,
Saint Genis Laval, France
University Heidelberg, Neuro-Urology clinic,
Heidelberg, Germany
St. Olavs Hospital HF, Neurologi clinic,
Trondheim, Norway
Gävle sjukhus, Urology clinic,
Gävle, Sweden
Rehab Station Stockholm,
Stockholm, Sweden
Sponsors and Collaborators
Coloplast A/S
Layout table for investigator information
Principal Investigator: Emmanuel Chartier-Kastler, Proff Hôpital Raymond poincarè, Service d'Urologie, Garches, France
Layout table for additonal information
Responsible Party: Coloplast A/S Identifier: NCT01523743    
Other Study ID Numbers: CP220
First Posted: February 1, 2012    Key Record Dates
Results First Posted: May 22, 2014
Last Update Posted: September 30, 2016
Last Verified: August 2016
Additional relevant MeSH terms:
Layout table for MeSH terms
Urinary Bladder, Neurogenic
Neurologic Manifestations
Nervous System Diseases
Urinary Bladder Diseases
Urologic Diseases